Evidence map›Paper›PMID 36292694›Full record

ArticleGenes2022

Clinical Course, Genetic, and Immunohistochemical Characterization of Solid Pseudopapillary Tumor of the Pancreas (Frantz Tumors) in a Brazilian Cohort.

Francinne T Tostes, Parisina Fraga Dutra Cabral de Carvalho, Raphael L C Araújo, Rodrigo Chaves Ribeiro, Franz Robert Apodaca-Torrez, Edson José Lobo, Diogo Bugano Diniz Gomes, Donato Callegaro-Filho, Gustavo Schvartsman, Fernando Moura and 5 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Francinne T TostesDepartment of Oncology, Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.ORCID 0000-0002-7831-0469
Parisina Fraga Dutra Cabral de CarvalhoDepartment of Surgery, Universidade Federal de Medicina do Estado de São Paulo, São Paulo 04023-062, Brazil.
Raphael L C AraújoDepartment of Oncology, Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.ORCID 0000-0002-7834-5944
Rodrigo Chaves RibeiroDepartment of Pediatric Surgery, Hospital de Cancer de Barretos Fundação PIO XII, Barretos 14784-370, Brazil.
Franz Robert Apodaca-TorrezDepartment of Surgery, Universidade Federal de Medicina do Estado de São Paulo, São Paulo 04023-062, Brazil.
Edson José LoboDepartment of Surgery, Universidade Federal de Medicina do Estado de São Paulo, São Paulo 04023-062, Brazil.
Diogo Bugano Diniz GomesDepartment of Oncology, Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.
Donato Callegaro-FilhoDepartment of Oncology, Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.
Gustavo SchvartsmanDepartment of Oncology, Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.
Fernando MouraDepartment of Oncology, Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.
Vladimir SchraibmanDepartment of Oncology, Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.
Alberto GoldenbergDepartment of Oncology, Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.
Fernanda Teresa de LimaCenter for Personalized Medicine, Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.
Vanderlei SegatelliDepartment of Pathology, Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.ORCID 0000-0002-5588-8508
Pedro Luiz Serrano Uson JuniorDepartment of Oncology, Hospital Israelita Albert Einstein, São Paulo 05652-900, Brazil.
Hospital Israelita Albert Einstein · BRUniversidade Federal de São Paulo · BRHospital de Câncer de Barretos · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Frantz tumors or solid pseudopapillary pancreatic neoplasm (SPN) are rare exocrine neoplasms that carry a favorable prognosis; they represent up to 3% of all tumors located in the region of the pancreas and have specific age and gender predispositions. In recent years, the rising curve of diagnosis is entitled to the evolution and access of diagnostic imaging. In this paper, we have retrospectively reviewed and described the clinical course of 40 patients with SPN from three institutions in Brazil, who had their diagnosis between 2005 and 2020, and analyzed the clinicopathological, genetic, and surgical aspects of these individuals. In accordance with the literature, most patients were women, 60% with unspecified symptoms at diagnosis, with tumors mainly located in the body and tail of the pancreas, of whom 70% underwent a distal pancreatectomy with sparing splenectomy as a standard procedure, and none of the cases have experienced recurrence to date. Surgery still remains the mainstay of treatment given the low metastatic potential, but more conservative approaches as observed in this cohort are evolving to become the standard of care. Herein, we present an in-depth analysis of cases focusing on the latest literature and report some of the smallest tumor cases in the literature. To our knowledge, this is the first report evaluating germline genetic testing and presenting a case of detected Li-Fraumeni syndrome.

Indexed as

Pancreatic NeoplasmsBrazilFemaleHumansMalePancreasPancreatectomyRetrospective StudiesFrantz tumorLi-Fraumeni syndromepancreatic tumorsolid pseudopapillary pancreatic neoplasm

Identifiers

PMID36292694
PMCPMC9601385
OpenAlexW4303685843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.